Optimization of the Lead Compound NVP-BHG712 as a Colorectal Cancer Inhibitor.


Journal

Chemistry (Weinheim an der Bergstrasse, Germany)
ISSN: 1521-3765
Titre abrégé: Chemistry
Pays: Germany
ID NLM: 9513783

Informations de publication

Date de publication:
21 Apr 2023
Historique:
received: 19 12 2022
pmc-release: 21 04 2024
medline: 28 4 2023
pubmed: 18 2 2023
entrez: 17 2 2023
Statut: ppublish

Résumé

The ephrin type-A receptor 2 (EPHA2) kinase belongs to the largest family of receptor tyrosine kinases. There are several indications of an involvement of EPHA2 in the development of infectious diseases and cancer. Despite pharmacological potential, EPHA2 is an under-examined target protein. In this study, we synthesized a series of derivatives of the inhibitor NVP-BHG712 and triazine-based compounds. These compounds were evaluated to determine their potential as kinase inhibitors of EPHA2, including elucidation of their binding mode (X-ray crystallography), affinity (microscale thermophoresis), and selectivity (Kinobeads assay). Eight inhibitors showed affinities in the low-nanomolar regime (K

Identifiants

pubmed: 36799129
doi: 10.1002/chem.202203967
pmc: PMC10133194
mid: NIHMS1876330
doi:

Substances chimiques

NVP-BHG712 0
Pyrazoles 0
Pyrimidines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202203967

Subventions

Organisme : Intramural NIH HHS
ID : ZIA SC010355
Pays : United States

Informations de copyright

© 2023 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH.

Références

Nucleic Acids Res. 2013 Jan;41(Database issue):D1063-9
pubmed: 23203882
ChemMedChem. 2012 Jun;7(6):1071-83
pubmed: 22529030
ChemMedChem. 2017 Jun 21;12(12):999-1011
pubmed: 28544567
J Oncol. 2020 Feb 27;2020:9342732
pubmed: 32184826
Clin Cancer Res. 2016 Jan 1;22(1):230-242
pubmed: 26283684
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Annu Rev Pharmacol Toxicol. 2015;55:465-87
pubmed: 25292427
Chem Biol. 2015 Jul 23;22(7):876-887
pubmed: 26165155
Clin Colorectal Cancer. 2013 Dec;12(4):267-274.e2
pubmed: 24050852
Mol Cancer Ther. 2019 Apr;18(4):845-855
pubmed: 30824612
Angiogenesis. 2010 Sep;13(3):259-67
pubmed: 20803239
J Clin Invest. 2014 May;124(5):2037-49
pubmed: 24713656
Front Oncol. 2020 Feb 12;10:125
pubmed: 32117772
J Med Chem. 2018 Sep 13;61(17):7977-7990
pubmed: 30075624
Chem Pharm Bull (Tokyo). 2016;64(8):1136-41
pubmed: 27477652
ACS Med Chem Lett. 2019 Nov 25;11(1):29-33
pubmed: 31938459
Mol Cell Oncol. 2018 Jul 23;5(4):e1465882
pubmed: 30250919
ACS Chem Biol. 2016 Dec 16;11(12):3400-3411
pubmed: 27768280
Mol Oncol. 2019 Nov;13(11):2441-2459
pubmed: 31545551
Br J Pharmacol. 2014 Dec;171(23):5195-208
pubmed: 24597515
ACS Chem Biol. 2019 Apr 19;14(4):655-664
pubmed: 30901187
N Engl J Med. 2019 Oct 24;381(17):1632-1643
pubmed: 31566309
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
ChemMedChem. 2018 Aug 20;13(16):1629-1633
pubmed: 29928781
ACS Chem Biol. 2015 Dec 18;10(12):2687-96
pubmed: 26390252
Chembiochem. 2016 Dec 2;17(23):2257-2263
pubmed: 27685543
Growth Factors. 2014 Dec;32(6):247-53
pubmed: 25418013
Eur J Med Chem. 2018 Jan 1;143:1261-1276
pubmed: 29128116
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67
pubmed: 22505256
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
J Proteome Res. 2015 Mar 6;14(3):1574-86
pubmed: 25660469
Cancer Prev Res (Phila). 2009 Dec;2(12):1039-49
pubmed: 19934338
Bioorg Med Chem Lett. 2009 Aug 1;19(15):4467-70
pubmed: 19553108
Nat Biotechnol. 2007 Sep;25(9):1035-44
pubmed: 17721511
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
EMBO Mol Med. 2018 Apr;10(4):
pubmed: 29438985
Nat Methods. 2013 Oct;10(10):989-91
pubmed: 23975139
Nat Commun. 2021 Dec 2;12(1):7047
pubmed: 34857764
Bioorg Med Chem Lett. 2014 Sep 1;24(17):4080-3
pubmed: 25124116
Cancer Res. 2001 Mar 1;61(5):2301-6
pubmed: 11280802
Mol Cell Proteomics. 2011 Dec;10(12):M111.011635
pubmed: 21955398
J Synchrotron Radiat. 2017 Jan 1;24(Pt 1):323-332
pubmed: 28009574
Mol Syst Biol. 2017 Nov 3;13(11):951
pubmed: 29101300
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Cancer Sci. 2004 Feb;95(2):136-41
pubmed: 14965363

Auteurs

Alix Tröster (A)

Center for Biomolecular Magnetic Resonance Institute for Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe University, Max-von-Laue-Straße 7, 60438, Frankfurt am Main, Germany.

Michael DiPrima (M)

Laboratory of Cellular Oncology Center for Cancer Research (CCR), National Cancer Institute (NCI), 37 Convent Drive, NIH Bethesda Campus Building 37, Room 4124, Bethesda, MD 20892, USA.

Nathalie Jores (N)

Center for Biomolecular Magnetic Resonance Institute for Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe University, Max-von-Laue-Straße 7, 60438, Frankfurt am Main, Germany.

Denis Kudlinzki (D)

Center for Biomolecular Magnetic Resonance Institute for Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe University, Max-von-Laue-Straße 7, 60438, Frankfurt am Main, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

Sridhar Sreeramulu (S)

Center for Biomolecular Magnetic Resonance Institute for Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe University, Max-von-Laue-Straße 7, 60438, Frankfurt am Main, Germany.

Santosh L Gande (SL)

Center for Biomolecular Magnetic Resonance Institute for Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe University, Max-von-Laue-Straße 7, 60438, Frankfurt am Main, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

Verena Linhard (V)

Center for Biomolecular Magnetic Resonance Institute for Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe University, Max-von-Laue-Straße 7, 60438, Frankfurt am Main, Germany.

Damian Ludig (D)

Center for Biomolecular Magnetic Resonance Institute for Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe University, Max-von-Laue-Straße 7, 60438, Frankfurt am Main, Germany.

Alexander Schug (A)

Center for Biomolecular Magnetic Resonance Institute for Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe University, Max-von-Laue-Straße 7, 60438, Frankfurt am Main, Germany.

Krishna Saxena (K)

Center for Biomolecular Magnetic Resonance Institute for Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe University, Max-von-Laue-Straße 7, 60438, Frankfurt am Main, Germany.

Maria Reinecke (M)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Emil-Erlenmeyer-Forum 5, 85354, Freising, Germany.
German Cancer Consortium (DKTK), Partner-Site Munich and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

Stephanie Heinzlmeir (S)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Emil-Erlenmeyer-Forum 5, 85354, Freising, Germany.

Matthias S Leisegang (MS)

Institute for Cardiovascular Physiology, Johann Wolfgang Goethe-University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Jan Wollenhaupt (J)

Macromolecular Crystallography, Helmholtz-Zentrum Berlin, Albert-Einstein-Str. 15, 12489, Berlin, Germany.

Frank Lennartz (F)

Macromolecular Crystallography, Helmholtz-Zentrum Berlin, Albert-Einstein-Str. 15, 12489, Berlin, Germany.

Manfred S Weiss (MS)

Macromolecular Crystallography, Helmholtz-Zentrum Berlin, Albert-Einstein-Str. 15, 12489, Berlin, Germany.

Bernhard Kuster (B)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Emil-Erlenmeyer-Forum 5, 85354, Freising, Germany.
German Cancer Consortium (DKTK), Partner-Site Munich and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Technical University of Munich, Emil-Erlenmeyer-Forum 5, 85354, Freising, Germany.

Giovanna Tosato (G)

Laboratory of Cellular Oncology Center for Cancer Research (CCR), National Cancer Institute (NCI), 37 Convent Drive, NIH Bethesda Campus Building 37, Room 4124, Bethesda, MD 20892, USA.

Harald Schwalbe (H)

Center for Biomolecular Magnetic Resonance Institute for Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe University, Max-von-Laue-Straße 7, 60438, Frankfurt am Main, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH